Millar Instruments, Inc. is a firm that produces medical device and develops pressure sensing technology. Recently, it has released the TRM53P implantable transmitter by teaming up with Telemetry Research, Ltd. The TRM53P is the world's foremost, completely implantable transmitter that merges Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
The TRM53P offers the facility to measure high-fidelity pressure that is able to deliver accurate pressures including dP/dT and LVP. It has a solid-state sensor mounted at the tip of the catheter which allows to measure pressure in most of the locations. In addition to that, the sensor lessens clotting and avoids the need for gel.
Data is transmitted digitally and possess wireless inductive power charging capabilities. This makes the system truly next generation. The digital data transmission helps to achieve a bigger monitoring range and true cohabitation of multiple animals. Monitoring is done 24/7 till the animal dies by making use of wireless inductive power charging facility.
The device offers exceptional long-term reliability, thus lessening overall expense. It has an integrated rechargeable battery thereby avoiding the need for restoration. This helps to repeatedly use straightforward transmitter.
Applications may include cardiovascular, sleep research, toxicology, safety testing, neuroscience and behavioral studies. By merging next generation technology with solid state pressure sensors, the TRM53P is designed to create a new standard for monitoring pressure.
Millar Instruments, Inc. designs, manufactures and markets pressure sensing technology which is mainly intended for use by medical researchers and clinicians. Millar integrated this technology into catheters for life science applications. Millar plays a vital role in this continuing research, by developing products and systems that aids to enhance medical advancements and discoveries.
Telemetry Research Ltd is based in Auckland, New Zealand. It designs, manufactures and markets implantable telemetry systems to wirelessly keep track of laboratory animals that is moving freely. Their implantable devices enhance quality of data and extend recording time, gather precise and predictive information for biomedical research etc. Their patented technology helps to send power wirelessly through the skin for recharging transmitters in vivo. This allows lifetime recording by means of updated digital data sampling and transmission.
Carolyn John is a Contributor to TMCnet. To read more of her articles, please columnist page.Edited by
Alice Straight